CD4 and B-cell chronic lymphocytic leukemia: Twenty-five percent (4/16) of patients with B-NHL, 30.76% (4/13) of patients with MM, and 27.27% (3/11) of patients with CLL were IFNγ-producing TCM CD4+ T lymphocyte HRs with values significantly higher than those observed in the HCs.